Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Addiction ; 114 Suppl 1: 24-34, 2019 10.
Artículo en Inglés | MEDLINE | ID: mdl-30702175

RESUMEN

AIMS: To determine whether a simple combination of level of smoking and level of vaping results in a useful typology for characterizing smoking and vaping behaviours. METHODS: Cross-sectional data from adults (≥ 18 years) in the 2016 wave 1 ITC Four Country Smoking and Vaping Survey in the United States (n = 2291), England (n = 3591), Australia (n = 1376) and Canada (n = 2784) were used. Participants who either smoked, vaped or concurrently used both at least monthly were included and divided into eight groups based on use frequency of each product (daily, non-daily, no current use). This resulted in four concurrent use groups (predominant smokers, dual daily users, predominant vapers and concurrent non-daily users). These groups were compared with each other and with the four exclusive use groups, on socio-demographics, nicotine dependence, beliefs and attitudes about both products, and quit-related measures using data weighted to reference population surveys in each country. RESULTS: Of the sample, 10.8% were concurrent users, with daily smokers vaping non-daily (predominant smokers), constituting 51.6% of this group. All eight categories differed from other categories on at least some measures. Concurrent daily nicotine users reported higher levels of indicators of nicotine dependence, and generally more positive attitudes toward both smoking and vaping than concurrent non-daily users. Among daily nicotine users, compared with exclusive daily smokers, reports of interest in quitting were higher in all concurrent use groups. Dual daily users had the most positive attitudes about smoking overall, and saw it as the least denormalized, and at the same time were equally interested in quitting as other concurrent users and were most likely to report intending to continue vaping. CONCLUSIONS: In Australia, Canada, England and the United States in 2016, daily nicotine users differed considerably from non-daily nicotine users. Among daily nicotine users, dual daily users (those who smoke and vape concurrently) should be treated as a distinct grouping when studying relationships between smoking and vaping. The eight-level typology characterizing concurrent and exclusive use of smoking and vaping should be considered when studying both products.


Asunto(s)
Nicotina/clasificación , Fumar/epidemiología , Productos de Tabaco/clasificación , Vapeo/epidemiología , Adolescente , Adulto , Anciano , Actitud Frente a la Salud , Australia , Canadá , Comorbilidad , Estudios Transversales , Investigación de Doble Uso/estadística & datos numéricos , Inglaterra , Encuestas Epidemiológicas/estadística & datos numéricos , Humanos , Persona de Mediana Edad , Estados Unidos , Adulto Joven
2.
Psychopharmacology (Berl) ; 227(1): 177-92, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23271193

RESUMEN

RATIONALE: The Drug Effects Questionnaire (DEQ) is widely used in studies of acute subjective response (SR) to a variety of substances, but the format of the DEQ varies widely across studies, and details of its psychometric properties are lacking. Thus, the field would benefit from demonstrating the reliability and validity of the DEQ for use across multiple substances. OBJECTIVE: The current study evaluated the psychometric properties of several variations of DEQ items, which assessed the extent to which participants (1) feel any substance effect(s), (2) feel high, (3) like the effects, (4) dislike the effects, and (5) want more of the substance using 100-mm visual analog scales. METHODS: DEQ data from three placebo-controlled studies were analyzed to examine SR to amphetamine, nicotine, and alcohol. We evaluated the internal structure of the DEQ for use with each substance as well as relationships between scale items, measures of similar constructs, and substance-related behaviors. RESULTS: Results provided preliminary psychometric support for items assessing each DEQ construct (feel, high, dislike, like, and more). CONCLUSIONS: Based on the study results, we identify several common limitations of extant variants of the DEQ and recommend an improved version of the measure. The simplicity and brevity of the DEQ combined with its promising psychometric properties support its use in future SR research across a variety of substances.


Asunto(s)
Anfetamina/administración & dosificación , Etanol/administración & dosificación , Nicotina/administración & dosificación , Encuestas y Cuestionarios/normas , Adulto , Anfetamina/clasificación , Bases de Datos Factuales/normas , Etanol/clasificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Nicotina/clasificación , Psicometría , Reproducibilidad de los Resultados , Adulto Joven
4.
Nicotine Tob Res ; 9(10): 1015-20, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17852768

RESUMEN

We used scanner data on cigarette prices and sales collected from supermarkets across the United States from 1994 to 2004 to test the hypothesis that cigarette prices are positively correlated with sales of cigarettes with higher tar and nicotine content. During this period the average inflation-adjusted price for menthol cigarettes increased 55.8%. Price elasticities from multivariate regression models suggest that this price increase led to an increase of 1.73% in sales-weighted average tar yields and a 1.28% increase in sales-weighted average nicotine yields for menthol cigarettes. The 50.5% price increase of nonmenthol varieties over the same period yielded an estimated increase of 1% in tar per cigarette but no statistically significant increase in nicotine yields. An ordered probit model of the impact of cigarette prices on cigarette strength (ultra-light, light, full flavor, unfiltered) offers an explanation: As cigarette prices increase, the probability that stronger cigarette types will be sold increases. This effect is larger for menthol than for nonmenthol cigarettes. Our results are consistent with earlier population-based cross-sectional and longitudinal studies showing that higher cigarette prices and taxes are associated with increasing consumption of higher-yield cigarettes by smokers.


Asunto(s)
Comercio/economía , Nicotina/análisis , Fumar/economía , Fumar/epidemiología , Breas/análisis , Industria del Tabaco/economía , Comercio/tendencias , Costos y Análisis de Costo , Humanos , Nicotina/clasificación , Fumar/tendencias , Breas/clasificación , Industria del Tabaco/estadística & datos numéricos , Contaminación por Humo de Tabaco/análisis , Estados Unidos/epidemiología
5.
Int J Health Serv ; 36(4): 747-66, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17175844

RESUMEN

The process of identifying carcinogens for purposes of health and safety regulation has been contested internationally. The U.S. government produces a "Report on Carcinogens" every two years, which lists known and likely human carcinogenic substances. In the late 1990s the tobacco industry responded to the proposed listing of secondhand smoke with a multi-part strategy. Despite industry efforts to challenge both the substance of the report and the agency procedures, environmental tobacco smoke was declared by the agency in 2000 to be a known human carcinogen. A subsequent lawsuit, launched by chemical interests but linked to the tobacco industry, failed, but it produced a particular legal precedent of judicial review that is favorable to all regulated industries. The authors argue that, in this case, tobacco industry regulation contradicts academic expectations of business regulatory victories. However, the tobacco industry's participation in the regulatory process influenced the process in favor of all regulated industry.


Asunto(s)
Carcinógenos/clasificación , Regulación Gubernamental , Política , Política Pública , Fumar/efectos adversos , Industria del Tabaco/legislación & jurisprudencia , Contaminación por Humo de Tabaco/efectos adversos , United States Dept. of Health and Human Services/organización & administración , Carcinógenos/toxicidad , Conflicto de Intereses , Toma de Decisiones en la Organización , Humanos , Nicotina/clasificación , Nicotina/toxicidad , Evaluación de Programas y Proyectos de Salud , Nicotiana/química , Industria del Tabaco/economía , Contaminación por Humo de Tabaco/análisis , Estados Unidos , United States Public Health Service
7.
Nature ; 376(6541): 539, 1995 Aug 17.
Artículo en Inglés | MEDLINE | ID: mdl-7637790
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA